Microfluidic applications centre Dolomite exceeds expectations
With engineers and biologists working flat out on commercial development projects, the Dolomite Centre has met all the original objectives, including facility refurbishment and ISO approval, amongst others. In its first year Dolomite has also created a new advisory group to augment its scientific and fabrication expertise, with professionals from sectors including Pharmaceuticals, Forensic Science, Medicine and Academia.
Minister for Science and Innovation, Malcolm Wicks said, "The UK has a proud history of innovation in science and technology. We believe that we must work with industry to develop the technology we'll need in the future, so that we can maintain our position as a leading global economy. That's why we're supporting the Dolomite Centre and its work in nanotechnology. It provides a great opportunity to harness the UK's world-class expertise and use it to boost our economy and our quality of life."
Most read news
Topics
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.